Logo image of PME

PINGTAN MARINE ENTERPRISE LT (PME) Stock Fundamental Analysis

USA - NASDAQ:PME - KYG7114V1023 - Common Stock

0.27 USD
-0.02 (-6.9%)
Last: 2/28/2023, 8:00:00 PM
Fundamental Rating

2

Overall PME gets a fundamental rating of 2 out of 10. We evaluated PME against 87 industry peers in the Food Products industry. Both the profitability and financial health of PME have multiple concerns. PME is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year PME has reported negative net income.
In the past year PME had a positive cash flow from operations.
PME Yearly Net Income VS EBIT VS OCF VS FCFPME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50M -50M -100M

1.2 Ratios

The profitability ratios for PME are negative, so there is not much use analyzing them.
Looking at the Return On Invested Capital, with a value of 6.76%, PME is in the better half of the industry, outperforming 71.74% of the companies in the same industry.
PME had an Average Return On Invested Capital over the past 3 years of 4.02%. This is significantly below the industry average of 28.34%.
The 3 year average ROIC (4.02%) for PME is below the current ROIC(6.76%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 6.76%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.02%
ROIC(5y)N/A
PME Yearly ROA, ROE, ROICPME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 20 -20 -40 -60 -80 -100

1.3 Margins

PME's Operating Margin of 17.81% is amongst the best of the industry. PME outperforms 97.83% of its industry peers.
In the last couple of years the Operating Margin of PME has declined.
The Profit Margin and Gross Margin are not available for PME so they could not be analyzed.
Industry RankSector Rank
OM 17.81%
PM (TTM) N/A
GM N/A
OM growth 3Y-25.51%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PME Yearly Profit, Operating, Gross MarginsPME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40 -40 -60 -80

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PME is creating some value.
The number of shares outstanding for PME has been increased compared to 1 year ago.
Compared to 1 year ago, PME has an improved debt to assets ratio.
PME Yearly Shares OutstandingPME Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M
PME Yearly Total Debt VS Total AssetsPME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M 500M

2.2 Solvency

PME has an Altman-Z score of 0.30. This is a bad value and indicates that PME is not financially healthy and even has some risk of bankruptcy.
PME's Altman-Z score of 0.30 is on the low side compared to the rest of the industry. PME is outperformed by 73.91% of its industry peers.
PME has a debt to FCF ratio of 25.89. This is a negative value and a sign of low solvency as PME would need 25.89 years to pay back of all of its debts.
The Debt to FCF ratio of PME (25.89) is comparable to the rest of the industry.
PME has a Debt/Equity ratio of 2.77. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of PME (2.77) is worse than 90.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.77
Debt/FCF 25.89
Altman-Z 0.3
ROIC/WACC1.51
WACC4.49%
PME Yearly LT Debt VS Equity VS FCFPME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M -100M 200M

2.3 Liquidity

PME has a Current Ratio of 0.75. This is a bad value and indicates that PME is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.75, PME is not doing good in the industry: 85.87% of the companies in the same industry are doing better.
A Quick Ratio of 0.50 indicates that PME may have some problems paying its short term obligations.
With a Quick ratio value of 0.50, PME is not doing good in the industry: 77.17% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.5
PME Yearly Current Assets VS Current LiabilitesPME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M

More info and screens

4

3. Growth

3.1 Past

PME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 96.01%, which is quite impressive.
PME shows a strong growth in Revenue. In the last year, the Revenue has grown by 88.08%.
The Revenue has been growing by 51.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)96.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5925.81%
Revenue 1Y (TTM)88.08%
Revenue growth 3Y36.65%
Revenue growth 5Y51.59%
Sales Q2Q%95.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PME Yearly Revenue VS EstimatesPME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M
PME Yearly EPS VS EstimatesPME Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 0.2 0.4 0.6 0.8 1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PME. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PME Price Earnings VS Forward Price EarningsPME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PME is valued cheaply inside the industry as 85.87% of the companies are valued more expensively.
PME's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PME is cheaper than 94.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.67
EV/EBITDA 6.97
PME Per share dataPME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PME does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PINGTAN MARINE ENTERPRISE LT

NASDAQ:PME (2/28/2023, 8:00:00 PM)

0.27

-0.02 (-6.9%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-29 2022-11-29/bmo
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner Change0%
Market Cap23.20M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF 1.67
P/OCF 0.41
P/B 0.35
P/tB 0.35
EV/EBITDA 6.97
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.16
FCFY59.87%
OCF(TTM)0.67
OCFY246.36%
SpS1.91
BVpS0.78
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 6.76%
ROICexc 6.84%
ROICexgc 6.84%
OM 17.81%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.02%
ROIC(5y)N/A
ROICexc(3y)4.02%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-22.39%
ROICexcg growth 5YN/A
ROICexc growth 3Y-22.39%
ROICexc growth 5YN/A
OM growth 3Y-25.51%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 2.77
Debt/FCF 25.89
Debt/EBITDA 8.22
Cap/Depr 297.9%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.5
Altman-Z 0.3
F-Score6
WACC4.49%
ROIC/WACC1.51
Cap/Depr(3y)609.14%
Cap/Depr(5y)610.22%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5925.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)88.08%
Revenue growth 3Y36.65%
Revenue growth 5Y51.59%
Sales Q2Q%95.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y504.12%
EBIT growth 3Y1.8%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y107.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y229.63%
OCF growth 3Y-18.06%
OCF growth 5YN/A